These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 35178099)
1. Molecular Assessment of Shi H; Liu J; Fan J; He L; Wang X; Tang F; Tian D; He Y Evid Based Complement Alternat Med; 2022; 2022():1988378. PubMed ID: 35178099 [TBL] [Abstract][Full Text] [Related]
2. Study on the mechanism of action of Yang AY; Liu HL; Yang YF Front Pharmacol; 2022; 13():1072547. PubMed ID: 36699068 [No Abstract] [Full Text] [Related]
3. [Mechanism of "Scutellaria barbata-Hedyotis diffusa" against breast cancer based on network pharmacology]. Jing XU; Feng-Qin S; Ke-Xin DU; Jia D; Dong-Yun LI Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(18):4448-4454. PubMed ID: 33164375 [TBL] [Abstract][Full Text] [Related]
4. Exploration of the effect and mechanism of Scutellaria barbata D. Don in the treatment of ovarian cancer based on network pharmacology and in vitro experimental verification. Zhang J; Qi C; Li H; Ding C; Wang L; Wu H; Dai W; Wang C Medicine (Baltimore); 2023 Dec; 102(51):e36656. PubMed ID: 38134066 [TBL] [Abstract][Full Text] [Related]
5. Network pharmacology and transcriptomics reveal the mechanisms of FFBZL in the treatment of oral squamous cell carcinoma. Zhao S; Xiao S; Wang W; Dong X; Liu X; Wang Q; Jiang Y; Wu W Front Pharmacol; 2024; 15():1405596. PubMed ID: 39323640 [TBL] [Abstract][Full Text] [Related]
6. Network pharmacology-based strategy to investigate the active ingredients and molecular mechanisms of Scutellaria Barbata D. Don against radiation pneumonitis. Sun PY; Wang AS; Zhang ZF; Zhang YL; Zheng X Medicine (Baltimore); 2021 Nov; 100(47):e27957. PubMed ID: 34964782 [TBL] [Abstract][Full Text] [Related]
7. Anti-Nasopharyngeal carcinoma mechanism of sanguinarine based on network pharmacology and molecular docking. Fan JY; Liu J; Zhang WQ; Lin T; Hu XR; Zhou FL; Tang L; He YC; Shi HJ Medicine (Baltimore); 2023 Dec; 102(48):e36477. PubMed ID: 38050231 [TBL] [Abstract][Full Text] [Related]
8. Exploring the mechanisms of anti-ovarian cancer of Hedyotis diffusa Willd and Scutellaria barbata D. Don through focal adhesion pathway. Xu X; Chen F; Zhang L; Liu L; Zhang C; Zhang Z; Li W J Ethnopharmacol; 2021 Oct; 279():114343. PubMed ID: 34147618 [TBL] [Abstract][Full Text] [Related]
9. Luteolin Isolated from Xiong Y; Zhong W; Liu J; Cheng B; Fan J; Zhou F; He L; Tian D; He Y Biomed Res Int; 2022; 2022():9740066. PubMed ID: 36588531 [TBL] [Abstract][Full Text] [Related]
10. Molecular Targets and Mechanisms of Niu K; Li Q; Liu Y; Qiao Y; Li B; Wei C; Wang K; Cui L; Zheng C; Wang R; Zhang L; Zhang H; Sun B; Yu B Evid Based Complement Alternat Med; 2021; 2021():9929093. PubMed ID: 34149863 [TBL] [Abstract][Full Text] [Related]
11. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification. Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740 [TBL] [Abstract][Full Text] [Related]
12. Molecular docking and network pharmacological analysis of Scutellaria baicalensis against renal cell carcinoma. Guo J; Mei ZW; Wang XJ; Li Q; Qin J Eur Rev Med Pharmacol Sci; 2023 Dec; 27(23):11574-11586. PubMed ID: 38095405 [TBL] [Abstract][Full Text] [Related]
13. Investigation of the Active Ingredients and Mechanism of Bi J; Lin Y; Sun Y; Zhang M; Chen Q; Miu X; Tang L; Liu J; Zhu L; Ni Z; Wang X Drug Des Devel Ther; 2021; 15():1075-1089. PubMed ID: 33727796 [TBL] [Abstract][Full Text] [Related]
14. AURKB, CHEK1 and NEK2 as the Potential Target Proteins of Huang C; Luo H; Huang Y; Fang C; Zhao L; Li P; Zhong C; Liu F Int J Gen Med; 2021; 14():3295-3312. PubMed ID: 34285555 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the Molecular Mechanism of Xu R; Yang X; Tao Y; Luo W; Xiong Y; He L; Zhou F; He Y J Healthc Eng; 2022; 2022():6277139. PubMed ID: 35463684 [TBL] [Abstract][Full Text] [Related]
16. Molecular Targets and Mechanisms of Yang Z; Lu S; Tang H; Qu J; Wang B; Wang Y; Pan G; Rao B Evid Based Complement Alternat Med; 2022; 2022():6186662. PubMed ID: 35707465 [No Abstract] [Full Text] [Related]
17. Exploring the Mechanism of Centipeda minima in Treating Nasopharyngeal Carcinoma Based on Network Pharmacology. Huang C; Liu X; Wang W; Guo Z Curr Comput Aided Drug Des; 2024 Oct; ():. PubMed ID: 39411942 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway. Liu H; Li X; Duan Y; Xie JB; Piao XL J Ethnopharmacol; 2021 May; 271():113907. PubMed ID: 33556477 [TBL] [Abstract][Full Text] [Related]
19. Network Pharmacology to Uncover the Molecular Mechanisms of Action of LeiGongTeng for the Treatment of Nasopharyngeal Carcinoma. Mi JL; Liu C; Xu M; Wang RS Med Sci Monit Basic Res; 2020 May; 26():e923431. PubMed ID: 32448862 [TBL] [Abstract][Full Text] [Related]
20. Anti-tumor effect of Scutellaria barbata D. Don extracts on ovarian cancer and its phytochemicals characterisation. Zhang L; Ren B; Zhang J; Liu L; Liu J; Jiang G; Li M; Ding Y; Li W J Ethnopharmacol; 2017 Jul; 206():184-192. PubMed ID: 28571726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]